The pharmacology of second-generation chimeric antigen receptors von van der Stegen, Sjoukje J. C., Hamieh, Mohamad, Sadelain, Michel

Volltext

CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape von Hamieh, Mohamad, Dobrin, Anton, Cabriolu, Annalisa, van der Stegen, Sjoukje J. C., Giavridis, Theodoros, Mansilla-Soto, Jorge, Eyquem, Justin, Zhao, Zeguo, Whitlock, Benjamin M., Miele, Matthew M., Li, Zhuoning, Cunanan, Kristen M., Huse, Morgan, Hendrickson, Ronald C., Wang, Xiuyan, Rivière, Isabelle, Sadelain, Michel

Volltext

Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells von Zhao, Zeguo, Condomines, Maud, van der Stegen, Sjoukje J.C., Perna, Fabiana, Kloss, Christopher C., Gunset, Gertrude, Plotkin, Jason, Sadelain, Michel

Volltext

Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4 von Wilkie, Scott, Burbridge, Sophie E., Chiapero-Stanke, Laura, Pereira, Ana C.P., Cleary, Siobhán, van der Stegen, Sjoukje J.C., Spicer, James F., Davies, David M., Maher, John

Volltext

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection von Eyquem, Justin, Mansilla-Soto, Jorge, Giavridis, Theodoros, van der Stegen, Sjoukje J. C., Hamieh, Mohamad, Cunanan, Kristen M., Odak, Ashlesha, Gönen, Mithat, Sadelain, Michel

Volltext

Engineered and banked iPSCs for advanced NK- and T-cell immunotherapies von Cichocki, Frank, van der Stegen, Sjoukje J. C., Miller, Jeffrey S.

Volltext

HLA-independent T cell receptors for targeting tumors with low antigen density von Mansilla-Soto, Jorge, Eyquem, Justin, Haubner, Sascha, Hamieh, Mohamad, Feucht, Judith, Paillon, Noémie, Zucchetti, Andrés Ernesto, Li, Zhuoning, Sjöstrand, Maria, Lindenbergh, Pieter L., Saetersmoen, Michelle, Dobrin, Anton, Maurin, Mathieu, Iyer, Archana, Garcia Angus, Andreina, Miele, Matthew M., Zhao, Zeguo, Giavridis, Theodoros, van der Stegen, Sjoukje J. C., Tamzalit, Fella, Rivière, Isabelle, Huse, Morgan, Hendrickson, Ronald C., Hivroz, Claire, Sadelain, Michel

Volltext

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling von Wilkie, Scott, van Schalkwyk, May C. I., Hobbs, Steve, Davies, David M., van der Stegen, Sjoukje J. C., Pereira, Ana C. Parente, Burbridge, Sophie E., Box, Carol, Eccles, Suzanne A., Maher, John

Volltext

Unraveling barriers to iPSC-derived CAR-T cell differentiation von van der Stegen, Sjoukje J.C., Rivière, Isabelle

Volltext

The Pluripotent Path to Immunotherapy von Diop, Mame P., van der Stegen, Sjoukje J.C.

Volltext

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? von van der Stegen, Sjoukje J C, Davies, David M, Wilkie, Scott, Foster, Julie, Sosabowski, Jane K, Burnet, Jerome, Whilding, Lynsey M, Petrovic, Roseanna M, Ghaem-Maghami, Sadaf, Mather, Stephen, Jeannon, Jean-Pierre, Parente-Pereira, Ana C, Maher, John

Volltext

Adoptive Cell Therapy from the Dish: Potentiating Induced Pluripotent Stem Cells von Lindenbergh, Pieter L., van der Stegen, Sjoukje J.C.

Volltext

Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells von van der Stegen, Sjoukje J. C., Lindenbergh, Pieter L., Petrovic, Roseanna M., Xie, Hongyao, Diop, Mame P., Alexeeva, Vera, Shi, Yuzhe, Mansilla-Soto, Jorge, Hamieh, Mohamad, Eyquem, Justin, Cabriolu, Annalisa, Wang, Xiuyan, Abujarour, Ramzey, Lee, Tom, Clarke, Raedun, Valamehr, Bahram, Themeli, Maria, Riviere, Isabelle, Sadelain, Michel

Volltext

CAR T-cell immunotherapy of MET-expressing malignant mesothelioma von Thayaparan, Thivyan, Petrovic, Roseanna M., Achkova, Daniela Y., Zabinski, Tomasz, Davies, David M., Klampatsa, Astero, Parente-Pereira, Ana C., Whilding, Lynsey M., van der Stegen, Sjoukje JC, Woodman, Natalie, Sheaff, Michael, Cochran, Jennifer R., Spicer, James F., Maher, John

Volltext

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin von Parente-Pereira, Ana C, Whilding, Lynsey M, Brewig, Nancy, van der Stegen, Sjoukje J C, Davies, David M, Wilkie, Scott, van Schalkwyk, May C I, Ghaem-Maghami, Sadaf, Maher, John

Volltext

The Development of Allogeneic Tips-Derived TCR- CAR+ CD8αβ T Cells von van der Stegen, Sjoukje J.C., Petrovic, Roseanna M., Lindenbergh, Pieter L., Diop, Mame P., Alexeeva, Vera, Xie, Hongyao, Clarke, Raedun, Valamehr, Bahram, Rivière, Isabelle, Sadelain, Michel

Volltext

Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells von Davies, David M, Foster, Julie, Van Der Stegen, Sjoukje J C, Parente-Pereira, Ana C, Chiapero-Stanke, Laura, Delinassios, George J, Burbridge, Sophie E, Kao, Vincent, Liu, Zhe, Bosshard-Carter, Leticia, Van Schalkwyk, May C I, Box, Carol, Eccles, Suzanne A, Mather, Stephen J, Wilkie, Scott, Maher, John

Volltext

Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid von Parente-Pereira, Ana C, Shmeeda, Hilary, Whilding, Lynsey M, Zambirinis, Constantinos P, Foster, Julie, van der Stegen, Sjoukje J C, Beatson, Richard, Zabinski, Tomasz, Brewig, Nancy, Sosabowski, Jane K, Mather, Stephen, Ghaem-Maghami, Sadaf, Gabizon, Alberto, Maher, John

Volltext

Development and Validation of a Good Manufacturing Process for IL-4-Driven Expansion of Chimeric Cytokine Receptor-Expressing CAR T-Cells von van Schalkwyk, May C. I., van der Stegen, Sjoukje J. C., Bosshard-Carter, Leticia, Graves, Helen, Papa, Sophie, Parente-Pereira, Ana C., Farzaneh, Farzin, Fisher, Christopher D., Hope, Andrew, Adami, Antonella, Maher, John

Volltext

Abstract 2309: T-cell development from T cell-derived induced pluripotent stem cell von van der Stegen, Sjoukje J.C., Themeli, Maria, Eyquem, Justin, Mansilla-Soto, Jorge, Sadelain, Michel

Volltext